These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. The Bile Acid-Phospholipid Conjugate Ursodeoxycholyl-Lysophosphatidylethanolamide (UDCA-LPE) Disintegrates the Lipid Backbone of Raft Plasma Membrane Domains by the Removal of the Membrane Phospholipase A2. Stremmel W; Staffer S; Fricker G; Weiskirchen R Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717968 [TBL] [Abstract][Full Text] [Related]
15. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192 [TBL] [Abstract][Full Text] [Related]
16. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001 [TBL] [Abstract][Full Text] [Related]
17. Hepatoprotectant ursodeoxycholyl lysophosphatidylethanolamide increasing phosphatidylcholine levels as a potential therapy of acute liver injury. Chamulitrat W; Zhang W; Xu W; Pathil A; Setchell K; Stremmel W Front Physiol; 2012; 3():24. PubMed ID: 22363296 [TBL] [Abstract][Full Text] [Related]
18. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627 [TBL] [Abstract][Full Text] [Related]
19. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats. Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896 [TBL] [Abstract][Full Text] [Related]
20. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]